BioHealth News
Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support
HONOLULU, HI, Mar. 12, 2025 – Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with…
Read More
WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 12, 2025 - Gaithersburg’s Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH) has brought in a…
Read More
CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it received comments from the U.S. Food and Drug Administration (FDA) on the confirmatory Registration…
Read More
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool…
Read More
Emergent and Rocketvax Partner on Next-Gen Product Development
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across…
Read More
Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics, is excited to announce…
Read More
IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program
COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that under its “at-the-market” equity…
Read More
Syngene Acquires its First Manufacturing Facility in Baltimore
BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO), today announced the acquisition of its…
Read More
MCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker
The life sciences industry is constantly evolving, influenced by new technologies, regulatory changes, and market dynamics. To help professionals stay informed, the MCCC Life…
Read More
Altimmune to Host Virtual R&D Day on March 13, 2025
GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will host a virtual R&D…
Read More
WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia
By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 5, 2025 - A New York health care technology company that recently adopted a…
Read More
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared…
Read More
Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)
ROCKVILLE, Md. and SUZHOU, China, March 05, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering,…
Read More
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients Rockville, MD – The U.S. Pharmacopeia (USP)…
Read More